Toshiya Noguchi
Taisho Pharmaceutical Co.
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Toshiya Noguchi.
Bioorganic & Medicinal Chemistry | 2009
Hideki Shinonaga; Toshiya Noguchi; Akiko Ikeda; Mari Aoki; Natsuko Fujimoto; Akira Kawashima
WNT-5A, a secretory glycoprotein, is related to the proliferation of dermal papilla cells. To develop a hair-growth stimulant, we have been searching for inhibitors of WNT-5A expression. We identified radicicol (1) as an active compound, and synthesized several radicicol derivatives. Among them, 6,7-dihydro-10alpha-hydroxy radicicol (31) was found to function as a new potent WNT-5A expression inhibitor with relatively low toxicity and excellent stability.
Bioorganic & Medicinal Chemistry | 2002
Toshiya Noguchi; Akira Onodera; Kazuyuki Tomisawa; Miyuki Yamashita; Kimiyo Takeshita; Sadakazu Yokomori
We have developed esonarimod, (+/-)-2-acetylthiomethyl-4-(4-methylphenyl)-4-oxobutanoic acid, as a new antirheumatic drug. Now we describe herein the preparation of the enantiomers of (+/-)-deacetylesonarimod, the pharmaceutically active metabolites of esonarimod, and comparison of their antirheumatic activities. No significant difference has been observed between the two enantiomers. In a pre-clinical study of esonarimod, other metabolites were detected in rat blood or urine. We also synthesized these compounds as authentic samples to analyze the human metabolites in clinical studies of esonarimod.
Heterocycles | 2002
Toshiya Noguchi; Akira Onodera; Kazuyuki Tomisawa; Sadakazu Yokomori
Three compounds with a dihydrothiophene ring were synthesized as authentic samples to analyze human metabolites of Esonarimod, which has been developed as a new antirheumatic drug.
Synthetic Communications | 2003
Toshiya Noguchi; Akira Onodera; Masato Ito; Mamoru Yoshida; Sadakazu Yokomori
Abstract An efficient large-scale synthesis of Esonarimod, (R,S)-2-acetylthiomethyl-4-(4-methylphenyl)-4-oxobutanoic acid (1), a new antirheumatic drug, was established. A small amount of water increased the yield of the Michael addition of thioacetic acid (4) to 2-methylene-4-(4-methylphenyl)-4-oxobutanoic acid (2) to give 1. Multikilogram amounts of 1 (over 25 kg) were successfully obtained using this procedure. In addition, this procedure was repeated nine times, and reproducible results were obtained. See Ref. [1]
Archive | 2005
Taro Kiyoto; Yasuhiro Tsutsui; Tadashi Tanaka; Sumie Shimada; Nobuhiko Nomura; Toshiya Noguchi; Fumihito Ushiyama; Yasunobu Ushiki
Archive | 2006
Taro Kiyoto; Tadashi Tanaka; Yasuhiro Tsutsui; Junichi Ando; Mai Motono; Yasuko Kawaguchi; Toshiya Noguchi; Yasunobu Ushiki; Fumihito Ushiyama; Hiroki Urabe
Archive | 2007
Taro Kiyoto; Junichi Ando; Tadashi Tanaka; Yasuhiro Tsutsui; Mai Yokotani; Toshiya Noguchi; Fumihito Ushiyama; Hiroki Urabe; Hiromasa Horikiri
Bioorganic & Medicinal Chemistry | 2003
Toshiya Noguchi; Masahiro Hasegawa; Kazuyuki Tomisawa; Morihiro Mitsukuchi
Chemical & Pharmaceutical Bulletin | 2002
Toshiya Noguchi; Akira Onodera; Kazuyuki Tomisawa; Sadakazu Yokomori
Archive | 2008
Taro Kiyoto; Masahiro Takebayashi; Yasutaka Baba; Muneo Syoji; Toshiya Noguchi; Fumihito Ushiyama; Hiroki Urabe; Hiromasa Horikiri